De Miglio Maria R, Virdis Patrizia, Calvisi Diego F, Frau Maddalena, Muroni Maria R, Simile Maria M, Daino Lucia, Careddu Giovanni M, Sanna-Passino Eraldo, Pascale Rosa M, Feo Francesco
Department of Biomedical Sciences, Division of Experimental Pathology and Oncology, University of Sassari, Sassari, Italy.
Cancer Res. 2006 Nov 1;66(21):10384-90. doi: 10.1158/0008-5472.CAN-06-2881.
Hepatocellular carcinoma (HCC) is prevalent in human and rodent males. Hepatocarcinogenesis is controlled by various genes in susceptible F344 and resistant Brown Norway (BN) rats. B alleles at Hcs4 locus, on RNO16, control neoplastic nodule volume. We constructed the F344.BN-Hcs4 recombinant congenic strain (RCS) by introgressing a 4.41-cM portion of Hcs4 from BN strain in an isogenic F344 background. Preneoplastic and neoplastic lesions were induced by the "resistant hepatocyte" protocol. Eight weeks after initiation, lesion volume and positivity for proliferating cell nuclear antigen (PCNA) were much higher in lesions of F344 than BN rats of both sexes. These variables were lower in females than in males. Lesion volume and PCNA values of male RCS were similar to those of F344 rats, but in females corresponded to those of BN females. Carcinomatous nodules and HCC developed at 32 and 60 weeks, respectively, in male F344 and congenics and, rarely, in F344 females. BN and congenic females developed only eosinophilic/clear cells nodules. Gonadectomy of congenic males, followed by beta-estradiol administration, caused a decrease in Ar expression, an increase in Er-alpha expression, and development of preneoplastic lesions comparable to those from BN females. Administration of testosterone to gonadectomized females led to Ar increase and development of preneoplastic lesions as in F344 males. This indicates a role of homozygous B alleles at Hcs4 in the determination of phenotypic patterns of female RCS and presence at Hcs4 locus of a high penetrance gene(s), activated by estrogens and inhibited/unaffected by testosterone, conferring resistance to females in which the B alleles provide higher resistance.
肝细胞癌(HCC)在人类和啮齿类雄性动物中普遍存在。肝癌发生受易感的F344大鼠和抗性的棕色挪威(BN)大鼠中的各种基因控制。位于RNO16上的Hcs4位点的B等位基因控制肿瘤结节体积。我们通过在同基因F344背景中导入来自BN品系的4.41-cM的Hcs4构建了F344.BN-Hcs4重组近交系(RCS)。采用“抗性肝细胞”方案诱导癌前病变和肿瘤病变。启动后8周,F344大鼠两性病变中的病变体积和增殖细胞核抗原(PCNA)阳性率均远高于BN大鼠。这些变量在雌性中低于雄性。雄性RCS的病变体积和PCNA值与F344大鼠相似,但雌性则与BN雌性大鼠的相应值一致。雄性F344大鼠和同基因大鼠分别在32周和60周时出现癌性结节和HCC,F344雌性大鼠中很少出现。BN和同基因雌性大鼠仅出现嗜酸性/透明细胞结节。对同基因雄性大鼠进行性腺切除,随后给予β-雌二醇,导致Ar表达降低,Er-α表达增加,并出现与BN雌性大鼠相当的癌前病变。对性腺切除后的雌性大鼠给予睾酮,导致Ar增加,并出现与F344雄性大鼠相同的癌前病变。这表明Hcs4位点的纯合B等位基因在决定雌性RCS的表型模式中起作用,并且在Hcs4位点存在一个高外显率基因,该基因被雌激素激活,受睾酮抑制/不受其影响,赋予B等位基因提供更高抗性的雌性大鼠抗性。